Global Brain has invested in medigle Co., Ltd. (medigle), a patient referral software provider striving to drive regional medical coordination, through its Meiji Yasuda Future Innovation Fund L.P. (Meiji Yasuda FIF). As medical costs keep increasing and medical resources are becoming scarce due to aging society, the importance of regional medical coordination, in which clinics and hospitals refer patients to each other, is growing. By optimizing medical resources through regional medical coordination, each medical institution can provide services according to its specialty. While the patient referral process within the regional medical coordination framework still involves many manual operations, the company offers “medigle Reservation,” which enables online booking for patient referrals, and “medigle CRM,” which enables sharing customer information within hospitals and analysis of patient referral data. Through these services, medigle is striving to promote IT-driven regional medical coordination. Global Brain has decided to invest in medigle, based on the company’s extensive knowledge in this area, its track record of being used by many flagship hospitals, and its potential for future development in regional medical coordination. Global Brain will contribute to medigle’s business growth in cooperation with Meiji Yasuda Life Insurance Company.

About medigle

Location: Osaka-shi, Osaka, Japan
Representative: Hideki Nakajima
Founded: January 2022
URL: https://medigle.jp/index.html
(Available only in Japanese)

About Meiji Yasuda FIF

Name: Meiji Yasuda Future Innovation Fund L.P.
General Partner: Global Brain Corporation
Fund Size: JPY 5 billion
Fund Term: 10 years

About Global Brain

Location: Tokyo, Japan
Representative: Yasuhiko Yurimoto
Founded: January 1998
URL: https://globalbrains.com

Global Brain has invested in medigle Co., Ltd., a patient referral software provider striving to drive regional medical coordination